Company / Operating Margin
Beta Bionics, Inc. Operating Margin History
FY2024-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-71.5%
FY2025
5-year range
-71.5% / -69.5%
FY2024-FY2025
Trend
-2.9%
vs FY2024
Sector context
#141 of 148
Health Care
What the data says
Among 148 Health Care companies, Beta Bionics, Inc. is in the bottom 5% for operating margin.
Based on SEC 10-K filings.
-71.5% in FY2025.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 5% in Health CareTop 95% of 148This company -71.5% Sector average -284.8%
▼
+74.9% above sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 2.9% year-over-year.
- Currently 213.3pp above the Health Care sector average.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -71.5% | -2.9% |
| FY2024 | -69.5% | - |
| FY2023 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026